ShockWave’s disruptive approach within the calcified cardiovascular disease space creates a first-mover advantage offering the opportunity of robust sales growth. ShockWave Medical’s business model ...

Rockville, MD, Feb. 19, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global shockwave therapy devices market was valued at US$ 1,832.6 ...

(Reuters) -Johnson & Johnson on Friday agreed to buy Shockwave Medical in a deal valued at $13.1 billion including debt, as it builds its cardiac-health-centric medical devices business to help drive ...

The present study was aimed to assess the safety and efficacy of a new dedicated shockwave device, 'Renova', which was designed to achieve substantially superior organ coverage, compared with the ...

DUBLIN, Dec. 18, 2020 /PRNewswire/ -- The "Extracorporeal Shockwave Device Global Market Insights 2020, Analysis and Forecast to 2025, by Manufacturers, Regions, Technology, Application" report has ...

SANTA CLARA, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc., a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified ...

SHEYERA introduces the DR-88 Shockwave Therapy Device, a state-of-the-art solution designed to provide non-invasive, precise pain relief and muscle rehabilitation. With advanced shockwave technology, ...

Shockwave Medical makes innovative medical devices used in intravascular lithotripsy (IVL), which involves the use of sonic pressure waves to treat calcified cardiovascular disease. Cardiovascular ...